SCHEMBL13613609

SCHEMBL13613609

Cc1ccc(CNC(=O)Nc2cccc3c2CC(O)CC3)cc1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 12/20 0.51
OPRM1 P35372 1/20 0.49
SMN1; SMN2 Q16637 5/20 0.47
NPC1 O15118 4/20 0.47
RAB9A P51151 4/20 0.47
HPGD P15428 3/20 0.47
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
TP53 P04637 2/20 0.47
ALDH1A1 P00352 2/20 0.44
KDM4E B2RXH2 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
GAA P10253 1/20 0.44
PKM P14618 1/20 0.44
ALOX15 P16050 1/20 0.44
HSD17B10 Q99714 1/20 0.44
TDP1 Q9NUW8 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2734756 0.97 TRPV1 (0.50) TRPV1OPRM1SMN1; SMN2NPC1RAB9A
SCHEMBL2734516 0.90 TRPV1 (0.47) TRPV1OPRM1SMN1; SMN2NPC1RAB9A
SCHEMBL13613606 0.90 TRPV1 (0.59) TRPV1OPRM1KDM4E
SCHEMBL13613608 0.89 TRPV1 (0.51) TRPV1OPRM1SMN1; SMN2NPC1RAB9A
SCHEMBL13613629 0.89 TRPV1 (0.53) TRPV1OPRM1MEN1KMT2ATP53
SCHEMBL13613627 0.89 TRPV1 (0.51) TRPV1OPRM1KDM4E
SCHEMBL13613612 0.89 TRPV1 (0.55) TRPV1OPRM1SMN1; SMN2NPC1RAB9A
SCHEMBL13613650 0.89 TRPV1 (0.51) TRPV1OPRM1KDM4E
SCHEMBL2734362 0.88 TRPV1 (0.45) TRPV1OPRM1SMN1; SMN2NPC1RAB9A
SCHEMBL13613614 0.88 KDM4E (0.56) TRPV1OPRM1SMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7612113-B2 Such as N-[4-chloro-3-(trifluoromethyl)phenyl]-N'-(7-hydroxy-5,6,7,8-tetrahydro-1-naphthalenyl)urea; vanilloid receptor antagonists; for treatment of urge urinary incontinence, overactive bladder, chronic pain, neuropathic pain, postoperative pain, rheumatoid arthritic pain, neuralgia, neuropathies, COPD XENTION LIMITED (GB) 2009-11-03 US disclosed
US-7612113-B2 Such as N-[4-chloro-3-(trifluoromethyl)phenyl]-N'-(7-hydroxy-5,6,7,8-tetrahydro-1-naphthalenyl)urea; vanilloid receptor antagonists; for treatment of urge urinary incontinence, overactive bladder, chronic pain, neuropathic pain, postoperative pain, rheumatoid arthritic pain, neuralgia, neuropathies, COPD XENTION LIMITED (GB) 2009-11-03 US disclosed